Long-Term Survival after Intensive Chemotherapy or Hypomethylating Agents in AML Patients Aged 70 Years and Older: A Large Patient Data Set Study from Dataml, SAL and Pethema European Registries

▪ The outcome of AML patients (pts) ≥ 70 years is poor. Defining the best treatment option remains controversial especially when choosing between intensive chemotherapy (IC) and hypomethylating agents (HMAs). We set up a multicentric European database collecting data of AML pts ≥ 70 y. The primary o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-11, Vol.138 (Supplement 1), p.872-872
Hauptverfasser:	Recher, Christian, Rollig, Christoph, Berard, Emilie, Bertoli, Sarah, Dumas, Pierre-Yves, Tavitian, Suzanne, Serve, Hubert, Bornhäuser, Martin, Platzbecker, Uwe, Müller-Tidow, Carsten, Baldus, Claudia D., Martínez-Cuadrón, David, Serrano, Josefina, Martínez, Pilar, Rodríguez-Arbolí, Eduardo, Gil, Cristina, Bergua, Juan-Miguel, Bernal, Teresa, de la Fuente, Adolfo, Delabesse, Eric, Bidet, Audrey, Pigneux, Arnaud, Montesinos, Pau, Kramer, Michael
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!